drugset / Trial / NCT02557685
Gut Microbiota Changes After Fecal Microbiota Transplantation
NaSingle-groupOpen-labelTreatment
Summary
This study aims to document early changes in the distal gut microbiota (both fecal and mucosa-associated) post FMT. Furthermore, whole blood and urine samples will facilitate collaborative immunologic and metabolomic analyses. This will be an open label clinical trial of FMT to prevent further recurrence in patients who have suffered at least a third episode of Clostridium difficile infection (CDI) and who have previously been treated with oral vancomycin.
Timeline
- Start
- 2015-06
- Primary completion
- 2016-03
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ornidazole | Other / unclassified | 300 ml | Other |